(Reuters) -Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage ...

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...

Trump officials are capitalizing on lingering COVID resentment to undermine American vaccine policy.

RNA vaccines were a game-changer in the fight against COVID-19 — but now, their future could be shifting. The U.S. Department ...

此次EMA的正面意见是Moderna防疫战略中的重要里程碑，标志着公司在疫苗研发与应对病毒变异方面的持续投入及成果。未来，该产品有望在欧洲多个国家推广使用，为应对COVID-19疫情及其对社会和公共卫生的影响提供有力保障。据悉，这款升级疫苗预计将在2025-2026免疫季全面推出，为更多年龄段人群带来保护效果。（编译自Moderna2025年7月25日新闻稿） ...

Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...

As the nation gears up for the rollout of an updated COVID-19 vaccine, a new study shows the economic benefits of continued ...

The Trump administration on Tuesday eliminated 22 mRNA vaccine development projects for COVID-19 and bird flu, a stark shift ...

Today on AirTalk, an update on COVID-19 funding and the latest on the future of vaccination efforts, the American Society of ...

HHS Secretary Robert F. Kennedy Jr. used discredited and misrepresented studies to justify canceling research into ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

在心血管疾病领域，药物诱发的心肌炎和心包炎一直是临床关注的潜在风险。尽管这些炎症性心脏疾病相对罕见，但其可能导致心力衰竭、心律失常甚至猝死等严重后果。近年来，随着免疫治疗药物和新型疫苗的广泛应用，药物相关心脏毒性的报道逐渐增多，但系统性研究仍显不足。特别是在COVID-19 mRNA疫苗接种后心肌炎病例激增的背景下，建立全面的药物-心脏炎症关联图谱显得尤为迫切。